BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19450926)

  • 1. Fecal proteases from diarrheic-IBS and ulcerative colitis patients exert opposite effect on visceral sensitivity in mice.
    Annaházi A; Gecse K; Dabek M; Ait-Belgnaoui A; Rosztóczy A; Róka R; Molnár T; Theodorou V; Wittmann T; Bueno L; Eutamene H
    Pain; 2009 Jul; 144(1-2):209-17. PubMed ID: 19450926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased faecal serine protease activity in diarrhoeic IBS patients: a colonic lumenal factor impairing colonic permeability and sensitivity.
    Gecse K; Róka R; Ferrier L; Leveque M; Eutamene H; Cartier C; Ait-Belgnaoui A; Rosztóczy A; Izbéki F; Fioramonti J; Wittmann T; Bueno L
    Gut; 2008 May; 57(5):591-9. PubMed ID: 18194983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R; Rosztóczy A; Leveque M; Izbéki F; Nagy F; Molnár T; Lonovics J; Garcia-Villar R; Fioramonti J; Wittmann T; Bueno L
    Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease activated receptor 2: a new target for IBS treatment.
    Bueno L
    Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():95-102. PubMed ID: 18924448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracolonic infusion of fecal supernatants from ulcerative colitis patients triggers altered permeability and inflammation in mice: role of cathepsin G and protease-activated receptor-4.
    Dabek M; Ferrier L; Annahazi A; Bézirard V; Polizzi A; Cartier C; Leveque M; Roka R; Wittmann T; Theodorou V; Bueno L
    Inflamm Bowel Dis; 2011 Jun; 17(6):1409-14. PubMed ID: 21560201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Luminal cathepsin g and protease-activated receptor 4: a duet involved in alterations of the colonic epithelial barrier in ulcerative colitis.
    Dabek M; Ferrier L; Roka R; Gecse K; Annahazi A; Moreau J; Escourrou J; Cartier C; Chaumaz G; Leveque M; Ait-Belgnaoui A; Wittmann T; Theodorou V; Bueno L
    Am J Pathol; 2009 Jul; 175(1):207-14. PubMed ID: 19528350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion.
    Caldarella MP; Milano A; Laterza F; Sacco F; Balatsinou C; Lapenna D; Pierdomenico SD; Cuccurullo F; Neri M
    Am J Gastroenterol; 2005 Feb; 100(2):383-9. PubMed ID: 15667496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
    Kerckhoffs AP; Ter Linde JJ; Akkermans LM; Samsom M
    Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS.
    Annaházi A; Ferrier L; Bézirard V; Lévêque M; Eutamène H; Ait-Belgnaoui A; Coëffier M; Ducrotté P; Róka R; Inczefi O; Gecse K; Rosztóczy A; Molnár T; Ringel-Kulka T; Ringel Y; Piche T; Theodorou V; Wittmann T; Bueno L
    Am J Gastroenterol; 2013 Aug; 108(8):1322-31. PubMed ID: 23711626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
    Li MR; Jiang K; Zhang QY
    Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):957-60. PubMed ID: 18756966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of change in an inhibitory neurotransmitter of the myenteric plexus on the pathogenetic mechanism of irritable bowel syndrome subgroups in rat models.
    Xu JR; Luo JY; Shang L; Kong WM
    Chin J Dig Dis; 2006; 7(2):89-96. PubMed ID: 16643336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased production of BDNF in colonic epithelial cells induced by fecal supernatants from diarrheic IBS patients.
    Wang P; Chen FX; Du C; Li CQ; Yu YB; Zuo XL; Li YQ
    Sci Rep; 2015 May; 5():10121. PubMed ID: 25998025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of the colorectal tonic reflex in female patients with irritable bowel syndrome.
    Ng C; Danta M; Kellow J; Badcock CA; Hansen R; Malcolm A
    Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G489-94. PubMed ID: 15905412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
    Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
    World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigation of visceral hyperesthesia in irritable bowel syndrome].
    Király A; Csizmadia C; Illés A; Undi S
    Orv Hetil; 2006 Mar; 147(9):421-6. PubMed ID: 16619961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.
    Kane SV; Sandborn WJ; Rufo PA; Zholudev A; Boone J; Lyerly D; Camilleri M; Hanauer SB
    Am J Gastroenterol; 2003 Jun; 98(6):1309-14. PubMed ID: 12818275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential vanilloid 4 mediates protease activated receptor 2-induced sensitization of colonic afferent nerves and visceral hyperalgesia.
    Sipe WE; Brierley SM; Martin CM; Phillis BD; Cruz FB; Grady EF; Liedtke W; Cohen DM; Vanner S; Blackshaw LA; Bunnett NW
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1288-98. PubMed ID: 18325985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leaky gut in patients with diarrhea-predominant irritable bowel syndrome and inactive ulcerative colitis.
    Gecse K; Róka R; Séra T; Rosztóczy A; Annaházi A; Izbéki F; Nagy F; Molnár T; Szepes Z; Pávics L; Bueno L; Wittmann T
    Digestion; 2012; 85(1):40-6. PubMed ID: 22179430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.